BUDESONIDE (ENTERIC COATED)

Product NDC
51862-580
11-digit product format
518620580
Labeler code
51862
Product ID
51862-580_d9a1678d-e215-4bed-a484-317d658fbe11
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
Budesonide
Dosage form
CAPSULE, DELAYED RELEASE PELLETS
Route
ORAL
Labeler
Mayne Pharma Inc.
Application
ANDA206623
Marketing category
ANDA
Marketing start
2019-10-31
Marketing end
0000-00-00
Substance
BUDESONIDE
Active strength
3 mg/1
Pharmacologic classes
Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]
NDC exclude flag
No
Listing certified through
2023-12-31
Current FDA listing
Historical FDA.report record

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
51862-580-01EA - Each51862-5809018b03f-3560-4c61-bd2c-d8525bd32a9212019-11-12

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
51862-580BUDESONIDE (ENTERIC COATED) (BUDESONIDE) CAPSULE, DELAYED RELEASE PELLETS [MAYNE PHARMA INC.]2Legacy NDC20221213_0659420e-e376-4b90-98bf-71af41c18676.zip

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionMarketing startMarketing endSampleExclude flagStatus
51862-580-0151862058001100 CAPSULE, DELAYED RELEASE PELLETS in 1 BOTTLE (51862-580-01) 2019-10-310000-00-00NoNoCurrent